Cosmetic cross-reference

Triacetin

CAS 102-76-1

Triacetin (CAS 102-76-1) is a Phase 2 pharmaceutical compound with 2 bioactivity targets and 15 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

2

SOURCE DrugCentral

Adverse signals

15

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Triacetin

CAS Number

102-76-1

UNII

XHX3C3X673

InChIKey

URAYPUMNDPQOKB-UHFFFAOYSA-N

ChEMBL ID

CHEMBL1489254

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2

Mid-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL1489254 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 2 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	Potency	12875.380000000001 nM	10	-
-	AC50	707.9 nM	1	-

SOURCE NLM RxNorm 4 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
TRIACETIN	10756	SU	MTHSPL
Triacetin	10756	SU	MTHSPL
triacetin	10756	SU	MTHSPL
triacetin	10756	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Triacetin used for in pharmaceutical contexts?

Triacetin (CAS 102-76-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Triacetin?

Triacetin has 15 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Anaemia, Drug ineffective, Drug interaction, Fall, Hydrocephalus. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Triacetin also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Triacetin with EU status "permitted".

What clinical phase is Triacetin in?

Triacetin is rendered with ChEMBL max phase 2.